Renaissance Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-123,913
| Closed | -$4.46M | – | 84 |
|
|
2023
Q1 | $4.46M | Sell |
123,913
-13,549
| -10% | -$488K | 3.31% | 7 |
|
|
2022
Q4 | $5.43M | Sell |
137,462
-2,428
| -2% | -$96K | 4.24% | 4 |
|
|
2022
Q3 | $5.62M | Sell |
139,890
-26,150
| -16% | -$1.05M | 3.61% | 4 |
|
|
2022
Q2 | $6.98M | Buy |
166,040
+63,988
| +63% | +$2.69M | 3.72% | 8 |
|
|
2022
Q1 | $3.98M | Sell |
102,052
-30,561
| -23% | -$1.19M | 1.69% | 17 |
|
|
2021
Q4 | $5.29M | Sell |
132,613
-23,235
| -15% | -$926K | 1.36% | 23 |
|
|
2021
Q3 | $5.63M | Sell |
155,848
-224,213
| -59% | -$8.1M | 1.14% | 24 |
|
|
2021
Q2 | $15.6M | Sell |
380,061
-72,887
| -16% | -$2.99M | 2.46% | 14 |
|
|
2021
Q1 | $19.8M | Buy |
452,948
+256,158
| +130% | +$11.2M | 2.93% | 9 |
|
|
2020
Q4 | $9.85M | Buy |
+196,790
| New | +$9.85M | 1.35% | 23 |
|